Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leg aneurysm complicating bacterial endocarditis. 2 cases].

B Escudier, J P Becquemin, J B Alexandre

    Presse Medicale (Paris, France : 1983)
    |June 11, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial.

    ESMO open·2024
    Same author

    Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study.

    ESMO open·2024
    Same author

    Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial.

    ESMO open·2024
    Same author

    Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study.

    ESMO open·2021

    Bacterial endocarditis can cause rare arterial aneurysms, particularly in leg arteries. Early diagnosis is challenging, often requiring advanced imaging like CT scans, with surgery typically necessary for treatment.

    Area of Science:

    • Cardiovascular Medicine
    • Infectious Diseases
    • Vascular Surgery

    Background:

    • Bacterial endocarditis is an infection of the heart's inner lining or valves.
    • Arterial aneurysms are abnormal bulges in artery walls.
    • Aneurysms are a rare but known complication of bacterial endocarditis.

    Observation:

    • Arterial aneurysms occurred in 1.1% of bacterial endocarditis cases.
    • Leg artery involvement was uncommon, seen in 6.6% of these aneurysms.
    • Two successful treatment cases of leg artery aneurysms are presented.

    Findings:

    • Initial misdiagnosis as phlebitis highlights diagnostic challenges.
    • Computerized tomography (CT) is crucial for accurate diagnosis.
    • Surgical intervention is the standard treatment approach.

    Related Experiment Videos

    Implications:

    • Increased awareness of arterial aneurysms as a complication of bacterial endocarditis is needed.
    • Early and accurate diagnosis through advanced imaging can improve patient outcomes.
    • Effective surgical management is vital for treating these rare vascular complications.